Clinical Trial Update: A Study to Evaluate the Usability of the SB11 PFS in Subjects With Wet AMD or Macular Oedema Secondary to RVO [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the usability of the SB11 prefilled syringe in subjects with wet age-related macular degeneration or macular edema due to retinal vein …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Macular Edema
• Neovascular Age-related Macular Degeneration
• Retinal Vein Occlusion

Drugs mentioned

• SB11 (ranibizumab)

Snippet

Sponsor: Samsung Bioepis Co., Ltd. | Conditions: Neovascular Age-related Macular Degeneration, Macular Edema | Phase 2 | Status: COMPLETED | Results posted: 2024-12-30